Arginine vasopressin

精氨加压素

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameArginine vasopressin
Drug Alias NameArgipressin精氨酸抗利尿激素Vasopressin精氨酸升压素Vasostrict +[9] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionVasopressin receptor agonists
TargetsVasopressin receptor
Therapy Area/IndicationsAutistic DisorderAutism Spectrum DisorderWounds and Injuries +[15] 
Global Approved IndicationsHypotension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPH Health LtdCentre Hospitalier Universitaire DijonStanford University +[5] 
Inactive CompaniesUniversity of Sao PauloUT Health San AntonioWake Forest University Health Sciences +[6] 
Active IndicationsAutistic DisorderAutism Spectrum DisorderAcute Pain +[9] 
Inactive IndicationsWounds and InjuriesShock, TraumaticHypertension +[6] 

Other Information

ATC CodeH01BA01
Related LinksWikipediaDrugBankKEGG